PRNewsWire
03 Mar 2026, 14:06 UTC · 31w ago
Verdict
Headline takes no side. We score GOSS −1.00 across three claims — strongly bearish.
−1.00strongly bearish
More negative than 95% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Zynex's former leadership faces federal fraud indictments and the company has filed for Chapter 11 bankruptcy following an $85 million forfeiture to Tricare.
More negative than 99% of claims this week
A securities class action lawsuit alleges Zynex's reported revenue growth was fueled by a fraudulent scheme of shipping medically unnecessary supplies and oversupplying patients.
So whatRevelations that a company's core revenue growth was driven by fraudulent billing rather than organic demand severely undermines its valuation and triggers massive legal liabilities.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More negative than 99% of claims this week
Zynex's common stock was suspended from NASDAQ on Dec. 24, 2025, and now trades over the counter as ZYXIQ.
So whatDelisting from a major exchange to OTC markets drastically reduces liquidity, institutional ownership, and investor confidence, resulting in severe downward pressure on the stock price.
More negative than 99% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is the target of a securities class action lawsuit.
More negative than 95% of ticker scores this week
Shares cratered following reports of delayed quarterly reports and material misstatements in financial reports.
More negative than 95% of ticker scores this week
The company filed for Chapter 11 bankruptcy, was delisted, and is facing federal fraud indictments and a securities class action lawsuit.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
6h ago
−72.8%
Price agrees with the score
$9.31 vs $34.29 close before publication (Mar 2) · not market-adjusted
GOSS chart →
